Market Overview

UPDATE: Morgan Stanley Upgrades Becton Dickinson to Equal-Weight on Margin, Organic Growth

Related BDX
Cardinal Health to Acquire AccessClosure - Analyst Blog
Balanced Risk-Reward for Covidien - Analyst Blog

Morgan Stanley raised its rating on Becton Dickinson (NYSE: BDX) from Underweight to Equal-weight and removed its price target of $68.

Morgan Stanley commented, "Upgrading BD to Equal-weight from Underweight. Organic growth and leverage are poised for a positive inflection after a two-year investment cycle. We are comfortable with valuation following 12% underperformance in 2012. To move to Overweight, we'd need better visibility on pipeline execution."

Becton Dickinson closed at $79.45 on Wednesday.

Posted-In: Morgan StanleyAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Most Popular

Related Articles (BDX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free